||represents shares of common stock underlying a time-based restricted stock unit award ("rsu"). effective as of june 14, 2023 (180 days following the merger, as defined below), the rsu will be vested as to 1/3 of the total number of shares and will continue to vest as to an additional 1/3 of the total number of shares on each of october 3, 2023 and october 3, 2024, subject to the continuing employment of the reporting person on each vesting date.
||received in connection with the issuer's merger (the "merger") with kineta, inc. ("legacy kineta") in accordance with the terms of the agreement and plan of merger dated as of june 5, 2022, as amended on december 5, 2022 (the "merger agreement"), by and among the issuer (f/k/a yumanity therapeutics, inc.), yacht merger sub, inc. and legacy kineta. the merger closed on december 16, 2022. pursuant to the terms of the merger agreement, each outstanding share of legacy kineta common stock was entitled to receive 0.0688 shares of common stock. the rsu was received in exchange for 100,000 shares of common stock underlying a legacy kineta rsu.
||the stock option vested as to 1/3 of the total number of shares on october 3, 2022, and an additional 1/3 of the total number of shares will vest on each yearly anniversary thereafter, until such time as the stock option is 100% vested, subject to the continuing employment of the reporting person on each vesting date.
||received in connection with the merger in exchange for options to acquire 200,000 shares of legacy kineta common stock for $1.86 per share.